After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Fate Therapeutics Inc is $174.26M. A total of 8.54 million shares were traded on the day, compared to an average of 3.20M shares.
In the most recent transaction, Bressi Jerome Charles sold 5,980 shares of FATE for 1.55 per share on Jan 10 ’25. After the transaction, the insider now owns 270,203 company shares. In a previous transaction on Jan 10 ’25, TAHL CINDY sold 5,654 shares at 1.55 per share. FATE shares that the insider owns now total 336,707.
Among the insiders who sold shares, Valamehr Bahram disposed of 8,705 shares on Jan 10 ’25 at a per-share price of $1.54. This resulted in the President and CEO holding 349,364 shares of FATE after the transaction. In another insider transaction, Valamehr Bahram bought 8,705 shares at $1.54 per share on Jan 10 ’25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, FATE has a high of $8.83 and a low of $1.04.
As of this writing, FATE has an earnings estimate of -$0.43 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of -$0.35 per share and a lower estimate of -$0.49.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. FATE’s latest balance sheet shows that the firm has $615.91M in Cash & Short Term Investments as of fiscal 2021. There were $114.82M in debt and $81.28M in liabilities at the time. Its Book Value Per Share was $3.18, while its Total Shareholder’s Equity was $678.84M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FATE is Buy with a score of 3.67.
